Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entity

GMP Bio

Tracked across 3 events · 35 articles · First seen Apr 06, 2026 · Last active Jun 04, 2026

Sentiment
3
Attention
4
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 10
Business
Impact: GMP Bio is a joint venture in which Oncotelic Therapeutics Inc. owns 45%, advancing its own pipeline of drug candidates that complement Oncotelic Therapeutics Inc.'s strategic position.
Apr 06, 2026 · 23 articles
4 0
2 0
Business
Apr 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track GMP Bio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.